Inefficacy Interim Monitoring Procedures in Randomized Clinical Trials: The Need to Report

ISSN： 1536-0075

Source： American Journal of Bioethics, Vol.11, Iss.3, 2011-03, pp. : 2-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Children's Oncology Group Routinely Applies “Lack of Efficacy” Interim Monitoring to Its Randomized Clinical Trials

By Anderson James Krailo Mark

American Journal of Bioethics, Vol. 11, Iss. 3, 2011-03 ,pp. : 18-19

Routledge Ltd

Access to resources Recommend Favorite

Precautionary Harm Disclosure in Clinical Trials

By Wu Kevin Chien-Chang

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 43-45

Routledge Ltd

Access to resources Recommend Favorite

Clinical Ethics Consultation: A Need for Evidence

By Magnus David

American Journal of Bioethics, Vol. 15, Iss. 1, 2015-01 ,pp. : 1-2

Routledge Ltd

Access to resources Recommend Favorite

Sham Surgery in Randomized Trials: Additional Requirements Should Be Satisfied

By Mann Howard

American Journal of Bioethics, Vol. 3, Iss. 4, 2003-0 ,pp. : 5-7

Routledge Ltd

Access to resources Recommend Favorite

Can Contracts Enhance Participant Autonomy in Clinical Trials?

By Buccafurni Diana

American Journal of Bioethics, Vol. 11, Iss. 4, 2011-04 ,pp. : 24-25

Routledge Ltd

Access to resources Recommend Favorite